Have a personal or library account? Click to login
Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability Cover

Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability

Open Access
|Dec 2018

Abstract

The aim of this study was to develop, optimize, and characterize a stable therapeutic bullfrog oil based nanoemulsion for oral application using a rational experimental design approach. The optimized oral nanoemulsion contained 0.2 % sodium benzoate and 0.02 % propyl-paraben as preservatives; 0.1 % sucralose and 0.4 % acesulfam K as sweeteners and 0.1 % tutti-frutti as flavoring to mask the unpleasant organoleptic characteristics of bullfrog oil. The oral O/W-nanoemulsion showed the droplet size, PDI, zeta potential, and pH of 410 ± 8 nm, 0.20 ± 0.02, –38 ± 2.5 mV, and 6.43 ± 0.05, respectively. The optimized oral nanoemulsion showed a milky single-phase and optimal physical stability at 25 °C for 90 days. Indeed, higher oxidation induction time and lower formation of peroxides in the oral nanoemulsion were responsible for improving its stability. A therapeutic delivery system containing bullfrog oil for oral application was successfully developed and optimized with ideal thermo-oxidative stability.

DOI: https://doi.org/10.2478/acph-2019-0001 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 33 - 48
Accepted on: Jul 9, 2018
|
Published on: Dec 7, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2018 Renata Rutckeviski, Francisco Humberto Xavier, Andreza Rochelle Do Vale Morais, Lucas Amaral-Machado, Everton Do Nascimento Alencar, Julieta Genre, Adriano Antunes De Souza Araujo, Eryvaldo Socrates Tabosa Do Egito, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.